Effects of colesevelam on insulin sensitivity in type 2 diabetes mellitus.

Trial Profile

Effects of colesevelam on insulin sensitivity in type 2 diabetes mellitus.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Colesevelam (Primary) ; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 01 Jan 2012 Results published in Diabetes, Obesity and Metabolism.
    • 01 Apr 2008 The expected completion date for this trial is now 1 Oct 2008, from clinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top